PROFESSIONAL ENGAGEMENT CAMPAIGN
Creative symbolizes the MOA of ANX005, a monoclonal antibody that inhibits C1q, the initiator of the classical complement pathway, that is activated by autoantibodies targeting peripheral nerves. ANX005 completely blocks the classical complement pathway but leaves the other branches (lectin and alternative pathways) of the complement system intact to fight infection.